Francine M Foss, MD

Professor of Medicine (Hematology) and of Dermatology

Clinical Interests

  • Lymphoma
  • Medical Oncology

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Child
Referrals: From physicians only

Patient Care Organizations


Cancer Center, Yale: Hematology Program

Yale Medical Group

Office of Cooperative Research

Board Certifications

  • Internal Medicine AB of Internal Medicine (1985)

  • Medical Oncology AB of Internal Medicine (1987)

Clinical Trials

Conditions Study Title
Lymphoid Leukemia, Phase I A Safety and Pharmacokinetic Study of BTCT4465A in NHL and CLL
Non-Hodgkin's Lymphoma Lenalidomide (CC-5013) plus R-CHOP Chemotherapy (R2-CHOP) versus placebo plus R-CHOP Chemotherapy
Non-Hodgkin's Lymphoma Phase 1/2 Intratumoral G100 in patients with Follicular Non-Hodgkin's Lymphoma
Mycosis Fungoides, Phase I MRG-106 injection in patients with cutaneous T-cell lymphoma (CTCL), mycosis fungoides (MF) sub-type
Hodgkin's Lymphoma, Leukemia, other, Multiple Myeloma, Non-Hodgkin's Lymphoma, Other Hematopoietic, Phase I An Open-Label Study of a Novel JAK-inhibitor,INCB052793,Given to Patients With Advanced Malignancies
Non-Hodgkin's Lymphoma, Other Hematopoietic Phase 1b Study of CC-122, CC-223, CC-292 and Rituximab in DLBCL
Multiple Myeloma A Phase 1b Study of the Safety and Pharmacokinetics of MPDL3280A (Anti-PD-L1 Antibody)
Lymphoid Leukemia Ibrutinib+Rituximab v. Fludarabine Phosphate, Cyclophosphamide, and Rituximab in untreated CLL
Non-Hodgkin's Lymphoma A Phase II Trial of PET-Directed Therapy for Limited Stage DLBCL (SWOG S1001)

Edit this profile

Contact Info

Francine M Foss, MD
Patient Care Location
Yale Cancer CenterYale-New Haven Hospital
20 York Street

New Haven, CT 06510
View on map...
Mailing Address
PO Box 208028
333 Cedar Street, TMP 3

New Haven, CT 06520-8028